GURUFOCUS.COM » STOCK LIST » Technology » Software » Sinopharm Tech Holdings Ltd (HKSE:08156) » Definitions » PEG Ratio

Sinopharm Tech Holdings (HKSE:08156) PEG Ratio : 0.01 (As of May. 05, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Sinopharm Tech Holdings PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Sinopharm Tech Holdings's PE Ratio without NRI is 0.31. Sinopharm Tech Holdings's 5-Year EBITDA growth rate is 42.60%. Therefore, Sinopharm Tech Holdings's PEG Ratio for today is 0.01.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Sinopharm Tech Holdings's PEG Ratio or its related term are showing as below:

HKSE:08156' s PEG Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.02   Max: 0.07
Current: 0.01


During the past 13 years, Sinopharm Tech Holdings's highest PEG Ratio was 0.07. The lowest was 0.01. And the median was 0.02.


HKSE:08156's PEG Ratio is ranked better than
99.87% of 770 companies
in the Software industry
Industry Median: 1.61 vs HKSE:08156: 0.01

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Sinopharm Tech Holdings PEG Ratio Historical Data

The historical data trend for Sinopharm Tech Holdings's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Tech Holdings PEG Ratio Chart

Sinopharm Tech Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.07

Sinopharm Tech Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.07 0.02 0.02

Competitive Comparison of Sinopharm Tech Holdings's PEG Ratio

For the Software - Application subindustry, Sinopharm Tech Holdings's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinopharm Tech Holdings's PEG Ratio Distribution in the Software Industry

For the Software industry and Technology sector, Sinopharm Tech Holdings's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Sinopharm Tech Holdings's PEG Ratio falls into.



Sinopharm Tech Holdings PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Sinopharm Tech Holdings's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=0.31016042780749/42.60
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Sinopharm Tech Holdings  (HKSE:08156) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Sinopharm Tech Holdings PEG Ratio Related Terms

Thank you for viewing the detailed overview of Sinopharm Tech Holdings's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinopharm Tech Holdings (HKSE:08156) Business Description

Traded in Other Exchanges
N/A
Address
Ruttonjee Centre, 11 Duddell Street, Unit 1802, 18/F, Ruttonjee House, Hong Kong Central, Hong Kong, HKG
Sinopharm Tech Holdings Ltd is an investment holding company. The company's operating segment includes Lottery-related services; Provision of Internet Plus services (solution and supply chain), Manufacturing and distribution of personal protective equipment, and Others services. It generates maximum revenue from the internet plus services (solution and supply chain) segment. The Internet plus Supply chain services segment includes the provision of supply chain management, data analysis and related services, and trading of goods through the internet platform. Geographically, it derives a majority of revenue from Hong Kong.

Sinopharm Tech Holdings (HKSE:08156) Headlines

No Headlines